JAKARTA - The Pharmaceutical BUMN Holding, PT Bio Farma (Persero) is cooperating with a British drugmaker, Profator Pharma. This collaboration is an effort by the government to strengthen national health security.
The collaboration between Bio Farma and Profactor Pharma was marked by the signing of a memorandum of understanding at the Indonesian Embassy in London, England, on Friday, September 30, 2022. The signing was also witnessed by the Minister of SOEs, Erick Thohir.
Erick said the government through SOEs is strengthening the national health security system. One of them is by improving the quality of health services for the community.
"The government through SOEs is strengthening the national health resilience system to improve the quality of service for the community," Erick wrote on his official Instagram account @erickthohir, Tuesday, October 4.
Erick said Bio Farma and Profactor Pharma will develop bleeding prevention drugs due to hemofelia and also genetic blood clot disorders. With this collaboration, according to Erick, Bio Farma can provide affordable pharmaceutical products.
Furthermore, Erick said the development of hemofolis drugs was still experiencing problems. Therefore, Erick hopes that with this collaboration, development constraints can be overcome.
"God willing, it can help the availability of hemofolis drugs, which have been an obstacle so far," he said.
Erick said, with the development of bleeding prevention drugs due to hemofelia and also this genetic blood clot disorder, children need not worry.
"Especially so that children with hemofolis are no longer worried about playing," he said.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
